Indeed, predictive ability of NT-proBNP for HFpEF remains to be challenged in T2DM patients due to increased proportion of patients having comorbidities (abdominal obesity and chronic kidney disease) that showed bidirectional influence on a clearance of natriuretic peptides [43]. The gene discussed is NPPB; the disease is chronic kidney disease.